Moderna Sends Its COVID-19 Vaccine To FDA For Emergency Use Authorization
Moderna announced Monday it will request emergency use authorization from the Food and Drug Administration for its COVID-19 vaccine.
Watch CBS News
Moderna announced Monday it will request emergency use authorization from the Food and Drug Administration for its COVID-19 vaccine.
People are staying hopeful and optimistic as Astra-Zeneca, Moderna and Pfizer all report their Covid-19 vaccines are "highly effective" in late trials.
Pfizer now says it's just "days away" from applying for federal approval of its potential COVID-19 vaccine.
Pfizer said its coronavirus vaccine was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns.
The legendary performer donated $1 million to coronavirus research at Vanderbilt University.
Reverend Liz Walker said she will work hard to get facts about the vaccine to the community.
When will the Moderna vaccine be available to the public?
Moderna said its COVID-19 vaccine appears to be 94.5% effective, according to preliminary data from the company's still ongoing study.
Dr. Anthony Fauci said Cambridge-based Moderna's announcement that its COVID-19 vaccine is 94.5% effective based on early data is "truly striking."
The company is now preparing data to send to the trial's Data and Safety Monitoring Board, an independent panel of experts.
Moderna says it is getting close to completing its vaccine after a trial that inclided 30,000 people.
Phase 3 is critical to determine if the vaccine works, said Dr. Lindsey Baden.
Moderna is one step closer to completing its coronavirus vaccine trial.
Moderna says the federal government could give approval for emergency use of its coronavirus vaccine by the end of the year.
Researchers at Brigham and Women's Hospital say that the trial for Moderna's coronavirus vaccine is going well.
Moderna said its' coronavirus vaccine won't be available to the general public until next spring.
Moderna said older patients are responding well to its coronavirus vaccine.
The FDA is expected to tell vaccine makers that they need to wait two months after giving all their study participants their second doses until they can ask to start emergency use of it.
Moderna may know as early as November whether or not its coronavirus vaccine works, according to its CEO.
The CEOs of nine bio-pharma companies, including from Moderna in Cambridge, have signed a pledge to put safety first as they develop a coronavirus vaccine.
A group of local science and research activists led a rally for an affordable coronavirus vaccine in Cambridge.
Moderna said a small group of older adults given it's experimental coronavirus vaccine showed encouraging early results.
Moderna has reached a deal with the Trump administration to supply 100 million doses of its coronavirus vaccine.
Dr. Anthony Fauci said he's "satisfied" with the enrollment in the first week of the first US Phase 3 clinical trial of a Covid-19 vaccine.
Moderna said it's coronavirus vaccine study is on track to complete enrollment of all 30,000 volunteers by next month.
